Cover Image
市場調查報告書

全球糖尿病市場

Global Diabetes Devices Market: Industry Analysis & Outlook 2017-2021

出版商 Koncept Analytics 商品編碼 223069
出版日期 內容資訊 英文 87 Pages
訂單完成後即時交付
價格
Back to Top
全球糖尿病市場 Global Diabetes Devices Market: Industry Analysis & Outlook 2017-2021
出版日期: 2017年09月16日 內容資訊: 英文 87 Pages
簡介

糖尿病是胰臟無法產生胰島素,或無法充分活用胰島素而產生的慢性疾病。糖尿病有第一型糖尿病,第二型糖尿病,妊娠性糖尿病3種。

本報告提供全球糖尿病市場相關調查分析、市場趨勢與發展、成長推動因素與課題、競爭情形、主要企業簡介等系統性資訊。

第1章 關於糖尿病

第2章 全球糖尿病市場

  • 糖尿病人口
  • 盛行率
  • 治療市場規模
  • 胰島素市場規模
  • 胰島素市場區隔
  • 明細:各地區

第3章 各地區分析

  • 西太平洋
  • 東南亞
  • 歐洲
  • 北美、加勒比海
  • 中東、北非
  • 中南美
  • 非洲

第4章 市場動態

  • 主要趨勢與發展
  • 成長推動因素
  • 課題

第5章 競爭情形

  • 全球市場
  • 各地區
    • 美國
    • 歐洲
    • 中國
    • 日本

第6章 企業簡介

  • 產業概要、財務概要、產業策略
    • Novo Nordisk
    • Sanofi
    • Eli Lilly
    • 武田藥品工業

第7章 市場預測

  • 市場預測
  • 預測手法

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Diabetes, referred to as diabetes mellitus by doctors, is a group of metabolic disorders which abnormally affect the level of sugar (glucose) in blood. Diabetes can either be due to pancreas not producing enough insulin or irresponsiveness of cells of the body to insulin. Insulin is a hormone which regulates the metabolism of carbohydrates, fat and protein by absorbing glucose (sugar) from the blood into fat, liver and skeletal muscles.

Diabetes devices are used in managing and treating diabetes and the market is filled with a vast variety of these devices. These devices can be broadly classified into two categories that include glucose monitoring and insulin pumps. Glucose monitoring devices are further divided into two type: traditional glucose monitoring and continuous glucose monitoring.

The U.S. is a major contributor to the global diabetes device market supported by increased ageing and obese population, better accessibility and favorable reimbursement policies for continuous glucose monitoring systems.

Continuous glucose monitoring was the most significant segment in the growth of global diabetes device market due to technological improvements in monitoring systems and increased recommendations by doctors. This segment is likely to witness a notable growth in future as well.

The global diabetes device market is expected to grow in future with increasing ageing population, obese population, rising spending on diabetes treatment, expanding patient pool suffering from diabetes, increasing disposable income and growing urbanization. Key trends of this market include increasing awareness towards diabetes devices, rising innovations in diabetes devices and adoption of sedentary lifestyle. However, there are some factors which can hinder the market growth including stringent legal norms, high costs and alternative treatments.

The report “Global Diabetes Devices Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., and Europe region along with the global market. The report profiles the key players of the market including Johnson & Johnson, Medtronic plc, Abbott Laboratories and DexCom Inc.

Table of Contents

1. Overview

  • 1.1. Diabetes
  • 1.2. Symptoms of Diabetes
  • 1.3. Diagnosis of Diabetes
  • 1.4. Diabetes Management
  • 1.5. Diabetes Devices

2. Global Diabetes Devices Market

  • 2.1. Diabetes Devices Market Value Forecast
  • 2.2. Diabetes Devices Market by Type
    • 2.2.1. Global Glucose Monitoring Devices Market by Value
    • 2.2.2. Global Glucose Monitoring Devices Market Value Forecast
    • 2.2.3. Global Traditional Glucose Monitoring Market by Value
    • 2.2.4. Global Traditional Glucose Monitoring Market Value Forecast
    • 2.2.5. Global Continuous Glucose Monitoring Market by Value
    • 2.2.6. Global Continuous Glucose Monitoring Market Value Forecast
    • 2.2.7. Global Insulin Pumps Market Value Forecast

3. Regional Market

  • 3.1. The U.S.
    • 3.1.1. The U.S. Diabetic Population
    • 3.1.2. The U.S. Diabetic Population Forecast
    • 3.1.3. The U.S. Diagnosed Diabetic Population
    • 3.1.4. The U.S. Diagnosed Diabetic Population Forecast
    • 3.1.5. The U.S. Diagnosed Diabetic Population by Type
    • 3.1.6. The U.S. Continuous Glucose Monitoring Market Forecast
    • 3.1.7. The U.S. CGM Type 1 Market by Volume
    • 3.1.8. The U.S. CGM Type 1 Market Volume Forecast
    • 3.1.9. The U.S. CGM Type 1 Market Volume by Patient Type
    • 3.1.10. The U.S. CGM Type 1 Market Volume Forecast by Type
    • 3.1.11. The U.S. Insulin Pump Market by Volume
    • 3.1.12. The U.S. Insulin Pump Market Volume Forecast
  • 3.2. Europe
    • 3.2.1. Europe Diabetic Population
    • 3.2.2. Europe Diabetic Population Forecast
    • 3.2.3. Europe Diabetic Population by Type
    • 3.2.4. Europe CGM Type 1 Market by Volume
    • 3.2.5. Europe CGM Type 1 Market Volume Forecast

4. Market Dynamics

  • 4.1. Growth Drivers
    • 4.1.1. Expanding Patient Pool Suffering from Diabetes
    • 4.1.2. Increasing Ageing Population
    • 4.1.3. Mounting Obese Population
    • 4.1.4. Increasing Life Expectancy
    • 4.1.5. Growing Spending on Diabetes Treatment
    • 4.1.6. Rising Urbanization
    • 4.1.7. Increasing Disposable Income
  • 4.2. Key Trends & Developments
    • 4.2.1. Increasing Awareness
    • 4.2.2. Increasing Innovation in Diabetes Devices
    • 4.2.3. Sedentary Lifestyle
  • 4.3. Challenges
    • 4.3.1. Stringent Legal Norms
    • 4.3.2. High Cost and Alternative Treatments

5. Competitive Landscape

  • 5.1. Global Market
    • 5.1.1. Revenue Comparison of Key Players
    • 5.1.2 Market Cap of Key Players
    • 5.1.3. Global CGM Market Share by Company
  • 5.2. The U.S.
    • 5.2.1. The U.S. CGM Market Volume Share by Company
    • 5.2.2. The U.S. CGM Type 1 Market Volume Share by Company
    • 5.2.3. The U.S. Insulin Pump Market Volume Share by Company

6. Company Profiles

  • 6.1. Johnson & Johnson
    • 6.1.1. Business Overview
    • 6.1.2. Financial Overview
    • 6.1.3. Business Strategies
  • 6.2. Medtronic Plc
    • 6.2.1. Business Overview
    • 6.2.2. Financial Overview
    • 6.2.3. Business Strategies
  • 6.3. Abbott Laboratories
    • 6.3.1. Business Overview
    • 6.3.2. Financial Overview
    • 6.3.3. Business Strategies
  • 6.4. DexCom, Inc.
    • 6.4.1. Business Overview
    • 6.4.2. Financial Overview
    • 6.4.3. Business Strategies

List of Charts

  • Type of Diabetes
  • Symptoms of Diabetes
  • Types of Diabetes Device
  • Global Diabetes Devices Market Value Forecast (2016-2021)
  • Global Diabetes Devices Market by Type (2016/2021)
  • Global Glucose Monitoring Devices Market by Value (2012-2016)
  • Global Glucose Monitoring Devices Market Value Forecast (2017-2021)
  • Global Traditional Glucose Monitoring Market by Value (2012-2016)
  • Global Traditional Glucose Monitoring Market Value Forecast (2017-2021)
  • Global Continuous Glucose Monitoring Market by Value (2012-2016)
  • Global Continuous Glucose Monitoring Market Value Forecast (2017-2021)
  • Global Insulin Pumps Market Value Forecast (2016-2021)
  • The U.S. Diabetic Population (2013-2016)
  • The U.S. Diabetic Population Forecast (2017-2021)
  • The U.S. Diagnosed Diabetic Population (2013-2016)
  • The U.S. Diagnosed Diabetic Population Forecast (2017-2021)
  • The U.S. Diagnosed Diabetic Population by Type (2016)
  • The U.S. Continuous Glucose Monitoring Market Forecast (2016-2021)
  • The U.S. CGM Type 1 Market by Volume (2013-2016)
  • The U.S. CGM Type 1 Market Volume Forecast (2017-2021)
  • The U.S. CGM Type 1 Market Volume by Patient Type (2013-2016)
  • The U.S. CGM Type 1 Market Volume Forecast by Type (2017-2021)
  • The U.S. Insulin Pump Market by Volume (2013-2016)
  • The U.S. Insulin Pump Market Volume Forecast (2017-2021)
  • Europe Diabetic Population (2013-2016)
  • Europe Diabetic Population Forecast (2017-2021)
  • Europe Diabetic Population by Type (2016)
  • Europe CGM Type 1 Market by Volume (2013-2016)
  • Europe CGM Type 1 Market Volume Forecast (2017-2021)
  • Global Diabetic Prevalence (2015/2040E)
  • Global Ageing Population (2012-2016)
  • Global Obese Population (2012-2016)
  • Global Life Expectancy at Birth (2012-2016)
  • Global Spending on Diabetes Treatment (2015/2040 E)
  • Global Urban Population (2012-2016)
  • Global GNI per Capita (2012-2016)
  • Revenue Comparison of Key Players (2016)
  • Market Cap Comparison of Key Players (2016)
  • Global CGM Market Share by Company (2016/2021)
  • The U.S. CGM Market Volume Share by Company (2016/2021)
  • The U.S. CGM Type 1 Market Volume Share by Company (2016/2021)
  • The U.S. Insulin Pump Market Volume Share by Company (2016/2021)
  • Johnson & Johnson Revenue by Product Segment (2016)
  • Johnson & Johnson Revenue and Net Earnings (2012-2016)
  • Johnson & Johnson Research and Development Expenditure (2013-2016)
  • Medtronic Plc Sales by Segment (2017*)
  • Medtronic Plc Net Sales and Net Earnings (2012-2017*)
  • Medtronic R&D Expenditure (2015-2017*)
  • Abbott Laboratories Sales by Segment (2016)
  • Abbott Laboratories Net Sales and Net Earnings (2012-2016)
  • Abbott Laboratories R&D Expenditure (2014-2016)
  • DexCom Revenue by Region (2016)
  • DexCom Inc. Total Revenue and Net Loss (2012-2016)
  • DexCom Inc. R&D Expenditure (2014-2016)
Back to Top